An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77731 · Cited by 632

Evaluation of nine commercial SARS-CoV-2 immunoassaysPreprint

Lassaunière, R., Frische, A., Harboe, Z. B., Nielsen, A. C. Y., Fomsgaard, A., Krogfelt, K. A., & Jørgensen, C. S. (2020) · medRxiv · doi:10.1101/2020.04.09.20056325 · Cited by 319

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015

Choe, P. G., Perera, R. A. P. M., Park, W. B., Song, K.-H., Bang, J. H., Kim, E. S., Kim, H. B., Ko, L. W. R., Park, S. W., Kim, N.-J., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2307.170310 · Cited by 227

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Bryant, J. E., Azman, A. S., Ferrari, M. J., Arnold, B. F., Boni, M. F., Boum, Y., Hayford, K. T., Luquero, F. J., Mina, M. J., Rodríguez-Barraquer, I., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc6347 · Cited by 142

Herd immunity is not a realistic exit strategy during a COVID-19 outbreakPreprint

Slot, E., Hogema, B. M., Reusken, C. B. E. M., Reimerink, J. H. J., Molier, M., Karregat, J. H. M., IJlst, J., Novotny, V. M. J., van Lier, R. A. W., & Zaaijer, H. L. (2020) · Research Square · doi:10.21203/rs.3.rs-25862/v1 · Cited by 55

Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein

Alandijany, T. A., El-Kafrawy, S. A., Tolah, A. M., Sohrab, S. S., Faizo, A. A., Hassan, A. M., Alsubhi, T. L., Othman, N. A., & Azhar, E. I. (2020) · Pathogens · doi:10.3390/pathogens9100803 · Cited by 40

Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden

Dopico, X. C., Muschiol, S., Christian, M., Hanke, L., Sheward, D. J., Grinberg, N. F., Rorbach, J., Bogdanović, G., McInerney, G. M., Allander, T., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13304 · Cited by 36

Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission

Boey, L., Roelants, M., Merckx, J., Hens, N., Desombere, I., Duysburgh, E., & Vandermeulen, C. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04222-9 · Cited by 36

Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays

Yun, S., Ryu, J. H., Jang, J. H., Bae, H., Yoo, S.-H., Choi, A., Jo, S. J., Lim, J., Lee, J., Ryu, H., et al. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.6.577 · Cited by 39

Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test

Kim, Y., Lee, J. H., Ko, G. Y., Ryu, J. H., Jang, J. H., Bae, H., Yoo, S.-H., Choi, A., Jung, J. H., Lee, J. M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11081496 · Cited by 38

Assessing the extent of SARS-CoV-2 circulation through serological studies

Koopmans, M., & Haagmans, B. L. (2020) · Nature Medicine · doi:10.1038/s41591-020-1018-x · Cited by 36

Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain

Poljak, M., Oštrbenk, A., Štamol, T., & Seme, K. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104784 · Cited by 36

Technical considerations to development of serological tests for SARS-CoV-2

Ernst, E., Wolfe, P., Stahura, C. M., & Edwards, K. A. (2020) · Talanta · doi:10.1016/j.talanta.2020.121883 · Cited by 36

Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study

Mortgat, L., Verdonck, K., Hutse, V., Thomas, I., Barbezange, C., Heyndríckx, L., Fischer, N., Vuylsteke, B., Kabouche, I., Ariën, K. K., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050824 · Cited by 33

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

Walker, G. J., Naing, Z., Stella, A. O., Yeang, M., Caguicla, J., Ramachandran, V., Isaacs, S. R., Agapiou, D., Bull, R. A., Stelzer‐Braid, S., et al. (2021) · Viruses · doi:10.3390/v13020247 · Cited by 36

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies

Velay, A., Gallais, F., Benotmane, I., Wendling, M.-J., Danion, F., Collange, O., Seze, J. D., Schmidt‐Mutter, C., Schneider, F., Bilbault, P., et al. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115181 · Cited by 35

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases

Kharlamova, N., Dunn, N., Bedri, S. K., Jerling, S., Almgren, M., Faustini, F., Gunnarsson, I., Rönnelid, J., Pullerits, R., Gjertsson, I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666114 · Cited by 37

Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant

Springer, D. N., Perkmann, T., Jani, C. M., Mucher, P., Prüger, K., Marculescu, R., Reuberger, E., Camp, J. V., Graninger, M., Borsodi, C., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02129-22 · Cited by 34

Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2

Müller, K., Girl, P., von Buttlar, H., Dobler, G., & Wölfel, R. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114122 · Cited by 33

An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens

Gillot, C., Douxfils, J., Cadrobbi, J., Laffineur, K., Dogné, J., Elsen, M., Eucher, C., Melchionda, S., Modaffari, É., Tré‐Hardy, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113752 · Cited by 33

Lateral Flow Immunoassays for SARS-CoV-2

Ang, G. Y., Chan, K., Yean, C. Y., & Yu, C. Y. (2022) · Diagnostics · doi:10.3390/diagnostics12112854 · Cited by 30

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children

Aleebrahim‐Dehkordi, E., Soveyzi, F., Deravi, N., Rabbani, Z. H., Saghazadeh, A., & Rezaei, N. (2020) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2020.10.020 · Cited by 33

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets

Ward, D., Higgins, M. K., Phelan, J. E., Hibberd, M. L., Campino, S. G., & Clark, T. G. (2021) · Genome Medicine · doi:10.1186/s13073-020-00822-6 · Cited by 33

Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa

Gededzha, M. P., Mampeule, N., Jugwanth, S., Zwane, N., David, A., Burgers, W. A., Blackburn, J. M., Grove, J. S., George, J. A., Sanne, I., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252317 · Cited by 28

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults

Wagner, A., Guzek, A., Ruff, J., Jasińska, J., Scheikl, U., Zwazl, I., Kundi, M., Stockinger, H. S. J., Farcet, M. R., Kreil, T. R., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00012-4 · Cited by 28

Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures

Ghodake, G. S., Shinde, S. K., Kadam, A. A., Saratale, R. G., Saratale, G. D., Syed, A., Elgorban, A. M., Marraiki, N., & Kim, D.-Y. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.112969 · Cited by 31

Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers

Lagerqvist, N., Maleki, K. T., Verner‐Carlsson, J., Olausson, M., Dillner, J., Byström, J. W., Monsen, T., Forsell, M. N. E., Eriksson, J., Bogdanović, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87289-6 · Cited by 31

A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics

Jalkanen, P., Pasternack, A. H., Maljanen, S., Melén, K., Kolehmainen, P., Huttunen, M., Lundberg, R., Tripathi, L., Khan, H., Ritvos, M. A., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab222 · Cited by 31

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

Nicholson, S. R., Karapanagiotidis, T., Khvorov, A., Douros, C., Mordant, F. L., Bond, K. A., Druce, J. D., Williamson, D. A., Purcell, D. F. J., Lewin, S. R., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab239 · Cited by 28

Saliva SARS-CoV-2 Antibody Prevalence in Children

Keuning, M. W., Grobben, M., de Groen, A.-E. C., Jong, E. P. B.-D., Bijlsma, M. W., Cohen, S., Felderhof, M. K., de Groof, F., Molanus, D., Oey, N. A., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00731-21 · Cited by 30

Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference

Graninger, M., Jani, C. M., Reuberger, E., Prüger, K., Gaspar, P., Springer, D. N., Borsodi, C., Weidner, L., Rabady, S., Puchhammer‐Stöckl, E., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02314-22 · Cited by 29

Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset

Sasisekharan, V., Pentakota, N., Jayaraman, A., Tharakaraman, K., Wogan, G. N., & Narayanasami, U. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021615118 · Cited by 30

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features

Rowntree, L. C., Chua, B. Y. L., Nicholson, S. R., Koutsakos, M., Hensen, L., Douros, C., Selva, K. J., Mordant, F. L., Wong, C. Y., Habel, J. R., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1258 · Cited by 29

Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks

Shafie, M. H., Dass, M. A., Shaberi, H. S. A., & Zainuddin, Z. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00342-3 · Cited by 34

Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19

Sadique, M. A., Yadav, S., Khan, R., & Srivastava, A. K. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00719g · Cited by 27

Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy

Milazzo, L., Lai, A., Pezzati, L., Oreni, L. M., Bergna, A., Conti, F., Meroni, C., Minisci, D., Galli, M., Corbellino, M., et al. (2021) · Occupational and Environmental Medicine · doi:10.1136/oemed-2020-107060 · Cited by 27

Simultaneous detection of the spike and nucleocapsid proteins from SARS-CoV-2 based on ultrasensitive single molecule assays

Cai, Q., Mu, J., Yang, L., Ge, J., Aryee, A. A., Zhang, X., & Li, Z. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03435-z · Cited by 31

Infection, recovery and re-infection of farmed mink with SARS-CoV-2

Rasmussen, T. B., Fonager, J., Jørgensen, C. S., Lassaunière, R., Hammer, A. S., Quaade, M. L., Boklund, A. E., Lohse, L., Strandbygaard, B., Rasmussen, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010068 · Cited by 28

Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusPreprint

Eyre, D. W., Lumley, S., Wei, J., Cox, S., James, T. J., Justice, A., Jesuthasan, G., O’Donnell, D., Howarth, A., Hatch, S. B., et al. (2021) · medRxiv · doi:10.1101/2021.03.21.21254061 · Cited by 28

Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study

Prakash, O., Solanki, B., Sheth, J. K., Joshi, B., Kadam, M., Vyas, S., Shukla, A. A., Tiwari, H., Rathod, S., Rajput, A., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044101 · Cited by 27

Comprehending COVID-19 diagnostic tests and greenness assessment of its reported detection methods

El‐Maghrabey, M., Magdy, G., Hashem, H. M., Amin, M. N., Elgaml, A., Radwan, A. S., El‐Sherbeny, M. A., & El-Shaheny, R. N. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117379 · Cited by 27

Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients

Gharbharan, A., GeurtsvanKessel, C. H., Jordans, C. C. E., Blaauw, M. J. T., van der Klift, M., Hassing, R., Smits-Zwinkels, M., Meertens, M., van den Hout, E. H. C., de Man, A. M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab647 · Cited by 26

Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins

Jodaylami, M. H., Djaïleb, A., Ricard, P., Lavallée, É., Cellier-Goetghebeur, S., Parker, M.-F., Coutu, J., Stuible, M., Gervais, C., Durocher, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00844-z · Cited by 28

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring

Cristiano, A., Pieri, M., Sarubbi, S., Pelagalli, M., Calugi, G., Tomassetti, F., Bernardini, S., & Nuccetelli, M. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108918 · Cited by 30

The Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center

Skrzat‐Klapaczyńska, A., Bieńkowski, C., Kowalska, J. D., Paciorek, M., Puła, J., Krogulec, D., Stengiel, J., Pawełczyk, A., Perlejewski, K., Osuch, S., et al. (2022) · Vaccines · doi:10.3390/vaccines10040552 · Cited by 27

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations

Nyagwange, J., Kutima, B., Mwai, K., Karanja, H., Gitonga, J. N., Mugo, D., Uyoga, S. M., Tuju, J., Ochola‐Oyier, L. I., Ndungu, F. M., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.105061 · Cited by 22

SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020

Coyer, L., Boyd, A. C., Schinkel, J., Agyemang, C. O., Galenkamp, H., Koopman, A. D. M., Leenstra, T., van Charante, E. P. M., van den Born, B. H., Lok, A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052752 · Cited by 23

Seroprevalence of SARS-CoV-2 after the Second Wave in South Africa in HIV-Infected and Uninfected Persons: A Cross-Sectional Household Survey, November 2020 – April 2021

Wolter, N., Tempia, S., von Gottberg, A., Bhiman, J. N., Walaza, S., Kleynhans, J., Moyes, J., Buys, A., McMorrow, M., Aitken, S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciac198 · Cited by 25

Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses

Sheta, S. M., & El‐Sheikh, S. M. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114680 · Cited by 24

B-Cell-Epitope-Based Fluorescent Quantum Dot Biosensors for SARS-CoV-2 Enable Highly Sensitive COVID-19 Antibody Detection

Zheng, Y., Song, K., Cai, K., Liu, L., Tang, D., Long, W., Zhai, B., Chen, J., Tao, Y., Zhao, Y., et al. (2022) · Viruses · doi:10.3390/v14051031 · Cited by 26

At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study

Byström, J. W., Vikström, L., Rosendal, E., Gröning, R., Gwon, Y.-D., Nilsson, E., Sharma, A., Espaillat, A., Hanke, L., McInerney, G. M., et al. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.13.2200432 · Cited by 22

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19

Tian, L., Elsheikh, E. B., Patrone, P. N., Kearsley, A. J., Gaigalas, A. K., Inwood, S., Lin‐Gibson, S., Esposito, D., & Wang, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052723 · Cited by 23

Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis

van der Togt, C. J. T., Cate, D. F. T., den Broeder, N., Rahamat-Langendoen, J. C., van den Bemt, B. J. F., & den Broeder, A. A. (2022) · Rheumatology · doi:10.1093/rheumatology/keac206 · Cited by 22

Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity

Thomas, S. N., Karger, A. B., Altawallbeh, G., Nelson, K. M., Jacobs, D. R., Gorlin, J. B., Barcelo, H., & Thyagarajan, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-12869-z · Cited by 24

Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals

Egia‐Mendikute, L., Bosch, A., Prieto‐Fernández, E., Lee, S. Y., Jiménez-Lasheras, B., Río, A. G.-D., Antoñana-Vildosola, A., Bruzzone, C., Bizkarguenaga, M., Embade, N., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02011-6 · Cited by 24

Neutralizing and binding antibody kinetics of COVID-19 patients during hospital and convalescent phasesPreprint

Yao, X., Liu, W. Y., Li, Z., Xiong, H., Su, Y., Li, T., Zhang, S., Zhang, X., Bi, Z., Deng, C.-X., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-327912/v1 · Cited by 23

More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation

Toon, K., Bentley, E. M., & Mattiuzzo, G. (2021) · Viruses · doi:10.3390/v13020217 · Cited by 23

Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches

Bouman, J. A., Riou, J., Bonhoeffer, S., & Regoes, R. R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008728 · Cited by 20

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Senegal: A National Population-Based Cross-Sectional Survey, between October and November 2020

Talla, C., Loucoubar, C., Roka, J. L., Barry, M. A., Ndiaye, S., Diarra, M., Thiam, M. S., Faye, O., Dia, M., Diop, M. M., et al. (2021) · IJID Regions · doi:10.1016/j.ijregi.2022.02.007 · Cited by 22

A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting

Hicks, S. M., Pohl, K. G., Neeman, T. M., McNamara, H. A., Parsons, K. M., He, J.-S., Ali, S. A., Nazir, S., Rowntree, L. C., Nguyen, T. H. O., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa623 · Cited by 22

Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients

Zonneveld, R., Jurriaans, S., van Gool, T., Hofstra, J. J., Hekker, T. A. M., Defoer, P., Haaften, P. E. B.-V., Wentink-Bonnema, E. M., Boonkamp, L., Teunissen, C. E., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104821 · Cited by 21

Numerical Investigation of Ag-Franckeite-Barium Titanium-BP-Based Highly Performed Surface Plasmon Resonance Sensor for Virus SARS-CoV-2 Detection

Vasimalla, Y., Pradhan, H. S., Pandya, R. J., Thiyaneswaran, B., Vanaja, S., Hossain, M. A., & Rashed, A. N. Z. (2023) · Plasmonics · doi:10.1007/s11468-023-01985-9 · Cited by 21

Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting

Marlet, J., Petillon, C., Ragot, E., Fattah, Y. A. E., Guillon, A., Marchand-Adam, S., Lemaignen, A., Bernard, L., Désoubeaux, G., Blasco, H., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104633 · Cited by 20

Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum

Krone, M., Gütling, J., Wagener, J., Lâm, T., Schoen, C. U., Vogel, U. F., Stich, A., Wedekink, F., Wischhusen, J., Kerkau, T., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-21 · Cited by 19

Understanding the association between sleep, shift work and COVID‐19 vaccine immune response efficacy: Protocol of the S‐CORE study

der Holst, H. M. L., Lammers, G. J., van der Horst, G. T. J., Chaves, I., de Vries, R. D., GeurtsvanKessel, C. H., Koch, B. C. P., & van der Kuy, P. H. M. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13496 · Cited by 20

Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies

Girl, P., Zwirglmaier, K., von Buttlar, H., Wölfel, R., & Müller, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.820151 · Cited by 19

Avoiding the self-nucleation interference: a pH-regulated gold in situ growth strategy to enable ultrasensitive immunochromatographic diagnostics

Duan, H. Q., Ma, T., Huang, X., Gao, B., Zheng, L., Chen, X., Xiong, Y., & Chen, X. S. (2022) · Theranostics · doi:10.7150/thno.70092 · Cited by 20

Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study

Yegorov, S., Kadyrova, I., Negmetzhanov, B., Kolesnikova, Y. A., Kolesnichenko, S. I., Korshukov, I., Baiken, Y., Matkarimov, B. T., Miller, M. S., Hortelano, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17514-3 · Cited by 21

Risks of SARS‐CoV‐2 transmission between free‐ranging animals and captive mink in the Netherlands

Sikkema, R. S., Begeman, L., Janssen, R., Wolters, W. J., GeurtsvanKessel, C. H., de Bruin, E., der Honing, R. W. H., Eblé, P. L., van der Poel, W. H. M., van den Brand, J. M. A., et al. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14686 · Cited by 20

Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods

Emmerich, P., von Possel, R., Hemmer, C. J., Fritzsche, C., Geerdes-Fenge, H. F., Menge, B., Messing, C., Borchardt‐Lohölter, V., Deschermeier, C., & Steinhagen, K. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27113 · Cited by 19

A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein

Faizo, A. A., Alandijany, T. A., Abbas, A. T., Sohrab, S. S., El-Kafrawy, S. A., Tolah, A. M., Hassan, A. M., & Azhar, E. I. (2021) · Diagnostics · doi:10.3390/diagnostics11050825 · Cited by 19

Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy

Napolitano, F., Giuseppe, G. D., Montemurro, M. V., Molinari, A. M., Donnarumma, G., Arnese, A., Pavía, M., & Angelillo, I. F. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094761 · Cited by 19

Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021

Lassaunière, R., Polacek, C., Fonager, J., Bennedbæk, M., Boding, L., Rasmussen, M., & Fomsgaard, A. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.49.2101059 · Cited by 19

SARS-CoV-2 Infection in Captive Hippos (Hippopotamus amphibius), Belgium

Vercammen, F., Cay, B., Gryseels, S., Balmelle, N., Joffrin, L., Hoorde, K. V., Verhaegen, B., Mathijs, É., van Vredendaal, R., Dharmadhikari, T., et al. (2023) · Animals · doi:10.3390/ani13020316 · Cited by 19

A rapid quantitative on-site coronavirus disease 19 serological test

Lee, J. H., Bae, P. K., Kim, H., Song, Y. J., Yi, S. Y., Kwon, J., Seo, J.-S., Lee, J.-M., Jo, H.-S., Park, S. M., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113406 · Cited by 18

Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies

Garritsen, A., Scholzen, A., van den Nieuwenhof, D. W. A., Smits, A. P. F., Datema, E. S., van Galen, L. S., & Kouwijzer, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1893378 · Cited by 15

Direct Immunodetection of Global A‐to‐I RNA Editing Activity with a Chemiluminescent Bioassay

Knutson, S. D., Arthur, R. A., Johnston, H. R., & Heemstra, J. M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102762 · Cited by 18

Toward Smart Diagnostics in a Pandemic Scenario: COVID-19

Hosseinifard, M., Naghdi, T., Morales‐Narváez, E., & Golmohammadi, H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.637203 · Cited by 19

Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study

Horn, M. P., Jónsdóttir, H. R., Brigger, D., Damonti, L., Suter‐Riniker, F., Endrich, O., Froehlich, T. K., Fiedler, M., Largiadèr, C. R., Marschall, J., et al. (2022) · Allergy · doi:10.1111/all.15206 · Cited by 21

Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The NetherlandsPreprint

Westerhuis, B. M., de Bruin, E., Chandler, F. D., Ramakers, C., Okba, N. M. A., Li, W., Goossens, H., de Jong, M. D., Bosch, B., Haagmans, B. L., et al. (2020) · medRxiv · doi:10.1101/2020.08.21.20177857 · Cited by 18

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19

Qin, X., Shen, J., Dai, E., Li, H., Tang, G., Zhang, L., Hou, X., Lu, M., Wu, X., Duan, S., et al. (2021) · BMC Immunology · doi:10.1186/s12865-021-00404-0 · Cited by 17

Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

Vauloup‐Fellous, C., Maylin, S., Périllaud-Dubois, C., Brichler, S., Alloui, C., Gordien, E., Rameix‐Welti, M., Gault, E., Moreau, F., Fourati, S., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04232-3 · Cited by 17

SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics

Ryzhov, I. M., Tuzikov, A. B., Nizovtsev, A. V., Baidakova, L. K., Galanina, O. E., Shilova, N. V., Зиганшина, М. М., Dolgushina, N. V., Bayramova, G. R., Sukhikh, G. T., et al. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00186 · Cited by 17

Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response

David, A., Scott, L. E., Jugwanth, S., Gededzha, M. P., Kahamba, T., Zwane, N., Mampeule, N., Sanne, I., Stevens, W. S., & Mayne, E. S. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.113096 · Cited by 17

High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination

Kadyrova, I., Yegorov, S., Negmetzhanov, B., Kolesnikova, Y. A., Kolesnichenko, S. I., Korshukov, I., Akhmaltdinova, L., Vazenmiller, D., Stupina, Y., Амирбековна, К. Н., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272008 · Cited by 17

High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020

Zhang, S., Ma, P., Orzechowski, M., Lemmer, A., Rzasa, K. M., Bagnall, J., Barkho, S., Chen, M., He, L. L., Neitupski, R., et al. (2023) · mBio · doi:10.1128/mbio.03523-22 · Cited by 16

Microfluidic biosensing platform integrated with flexible sensing array for cancer biomarker point-of-care testing

Zhang, Y., Sun, M., Zhou, H., Zhang, Y., Qiu, J., Cheng, X., Wang, C., Ning, Y., Xing, J., Xu, S., et al. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.137148 · Cited by 16

An original multiplex method to assess five different SARS-CoV-2 antibodies

Favresse, J., Brauner, J., Bodart, N., Vigneron, A., Roisin, S., Melchionda, S., Douxfils, J., & Ocmant, A. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1652 · Cited by 17

COVID ‐19 antibody screening with SARS‐CoV ‐2 red cell kodecytes using routine serologic diagnostic platforms

Nagappan, R., Flegel, W. A., Srivastava, K., Williams, E. C., Ryzhov, I. M., Tuzikov, A. B., Galanina, O. E., Shilova, N. V., Sukhikh, G. T., Perry, H. E., et al. (2021) · Transfusion · doi:10.1111/trf.16327 · Cited by 17

Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability

Guilger‐Casagrande, M., de Barros, C. T., Antunes, V. A. N., de Araújo, D. R., & de Lima, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.598875 · Cited by 17

SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET

Cecon, E., Burridge, M., Cao, L., Carter, L. P., Ravichandran, R., Dam, J., & Jockers, R. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.06.008 · Cited by 17

SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey

Chimeddorj, B., Mandakh, U., Le, L., Bayartsogt, B., Deleg, Z., Enebish, O., Altanbayar, O., Magvan, B., Gantumur, A., Byambaa, O., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100317 · Cited by 16

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey

Vette, K., Machalek, D. A., Gidding, H. F., Nicholson, S. R., O'Sullivan, M. V. N., Carlin, J. B., Downes, M., Armstrong, L., Beard, F., Dwyer, D. E., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac002 · Cited by 15

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary

Wouters, E., Steenhuis, M., Schrezenmeier, H., Tiberghien, P., Harvala, H., Feys, H. B., & van der Schoot, C. E. (2020) · Vox Sanguinis · doi:10.1111/vox.13060 · Cited by 15

How can we interpret SARS-CoV-2 antibody test results?

Føns, S., & Krogfelt, K. A. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa069 · Cited by 17

Gold nanostructures modified carbon-based electrode enhanced with methylene blue for point-of-care COVID-19 tests using isothermal amplification

Kim, H. E., Schuck, A., Park, H., Huh, H. J., Kang, M., & Kim, Y. (2023) · Talanta · doi:10.1016/j.talanta.2023.124841 · Cited by 15

Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports

Emeribe, A. U., Abdullahi, I. N., Shuwa, H. A., Uzairue, L. I., Musa, S., Anka, A. U., Adekola, H. A., Bello, Z. M., Rogo, L. D., Aliyu, D., et al. (2021) · International Health · doi:10.1093/inthealth/ihab005 · Cited by 15

Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples

Hanssen, D. A. T., Slaats, M., Mulder, M., Savelkoul, P. H. M., & van Loo, I. H. M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04220-7 · Cited by 15

Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes

Roy, S. S., & Demmer, R. T. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.002 · Cited by 17

Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood

Campbell, C., Padmanabhan, N., Romero, D., Joe, J., Gebremeskel, M., Manjula, N., Wohlstadter, N., Wohlstadter, R., Goodwin, P., Quintero, L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10484-6 · Cited by 14

Recent advances in immunoassay technologies for the detection of human coronavirus infections

Wang, D., Chen, Y., Shan, X., Hu, H., Zhan, Y., Yu, Y., Zhang, J., Wu, P., Liu, F. Y., Kai, T., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1040248 · Cited by 16

Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice

Plebani, M., Padoan, A., Sciacovelli, L., & Basso, D. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0880 · Cited by 14

Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021–June 2022): secondary analysis of a prospective cohort study

Jorgensen, P., Schmid, A. M., Sulo, J., Preza, I., Hasibra, I., Kissling, E., Fico, A., Sridhar, S., Rubin-Smith, J. E., Kota, M., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100584 · Cited by 13

SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method—A Small Real-World Sample Exploration

Li, X., Liang, C., & Xiao, X. (2021) · Vaccines · doi:10.3390/vaccines9101139 · Cited by 15

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting

Montomoli, E., Apolone, G., Manenti, A., Boeri, M., Suatoni, P., Sabia, F., Marchianò, A. V., Bollati, V., Pastorino, U., & Sozzi, G. (2021) · Viruses · doi:10.3390/v14010061 · Cited by 13

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

Nicholson, S. R., Karapanagiotidis, T., Khvorov, A., Douros, C., Mordant, F. L., Bond, K. A., Druce, J. D., Williamson, D. A., Purcell, D. F. J., Lewin, S. R., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab239 · Cited by 28

Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test

Bal, A., Pozzetto, B., Trabaud, M., Escuret, V., Rabilloud, M., Langlois, C., Paul, A., Guibert, N., d’Aubarede, C., Massardier-Pilonchery, A., et al. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvaa336 · Cited by 74

Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays

Xue, H., Haynesworth, K., Hempel, H., Kemp, T. J., & Pinto, L. A. (2026) · Vaccines · doi:10.3390/vaccines14050395

Comparison of different serological assays for SARS-CoV-2 in real life

Brochot, É., Demey, B., Handala, L., François, C., Duverlie, G., & Castelain, S. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104569 · Cited by 43

A Comparison of the Performance of SARS-CoV-2 Antibody Assays in Healthcare Workers with COVID-19.

Kerr, C., Dunne, J., Hughes, G., Cox, F., Healy, M., Holmes, P., O'Rourke, F., O'Brien, C., Coyne, D., Crowley, V., et al. (2021) · PubMed · Cited by 2